Europe
Biotech and pharma companies strengthen their executive leadership and board positions.
Companies from across the globe provide information on agreements and pipeline updates.
Amarin Corporation, based in Bedminster, New Jersey and Dublin, Ireland, provided a mid-year update, noting that it is planning to dramatically expand its sales force for Vascepa.
Dicerna Pharmaceuticals, headquartered in Cambridge, Massachusetts, announced it has submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA).
Sandoz announced its donation of over 4,000 packs of SYMJEPI™ 0.3 mg Injection for immediate use in free and charity clinics in the US through its collaboration with Americares.
Novartis announced that it has completed its acquisition of Xiidra® 5%, the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.
Bittium Wearable Platform with Philips EmoGraphy & CardioSense Solution Was Awarded in the GSK’s “Transform the Future of Self-Care” Innovation Contest
CENTOGENE revealed the growth in its knowledge-base of rare hereditary diseases.
Ascension Healthcare plc announces positive findings from its Flexiseq User Experience Study.
Financial details of the deal were not disclosed, but Lonza said it plans to retain the Novartis employees currently working at the facility.
PRESS RELEASES